Last reviewed · How we verify
NCT03881137
Improved Function and Quality of Life for Older Patients Receiving Radiotherapy, Part II
NA trial testing Geriatric assessment with management in Cancer in 178 participants. Completed in 10 June 2022.
25 July 2021
Quick facts
| Lead sponsor | Sykehuset Innlandet HF |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 178 |
| Start date | 8 May 2019 |
| Primary completion | 25 July 2021 |
| Estimated completion | 10 June 2022 |
| Sites | 2 locations across Norway |
Drugs / interventions tested
- Geriatric assessment with management
Conditions studied
- Cancer — all drugs for Cancer →
- Radiotherapy — all drugs for Radiotherapy →
- Older Patients — all drugs for Older Patients →
Sponsor
Sykehuset Innlandet HF — full company profile →
Who can join
65 and older, any sex, with Cancer or Radiotherapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This cluster randomized controlled pilot study is designed to test the feasibility, and potential effect of a multicomponent, community-based intervention aiming to improve quality of life (QoL) and function for older patients receiving radiotherapy (RT), and thereby reduce the needs for professional help. The intervention will be based on geriatric assessment and management (GAM), i.e. systematic assessment and management of physical, mental and functional problems frequently occurring in the elderly. It will target individual patients according to needs and be carried out in collaboration between hospital and community services from start of RT until 8 weeks post-treatment.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Geriatric assessment with management for older patients with cancer receiving radiotherapy. Protocol of a Norwegian cluster-randomised controlled pilot study.
Røyset I, Saltvedt I, Rostoft S, Grønberg BH, et al · · 2022 · cited 5× · PMID 34776384 · DOI 10.1016/j.jgo.2021.11.001 -
Experiences With an Intervention Based on Geriatric Assessment With Management: A Qualitative Study.
Sollid MIV, Melby L, Slaaen M, Eilertsen G, et al · · 2025 · PMID 40223637 · DOI 10.1002/nop2.70220 -
Geriatric assessment with management for older patients with cancer receiving radiotherapy: a cluster-randomised controlled pilot study.
Slaaen M, Røyset IM, Saltvedt I, Grønberg BH, et al · · 2024 · PMID 38853251 · DOI 10.1186/s12916-024-03446-4
Verify or expand the search:
- PubMed search for NCT03881137
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Sykehuset Innlandet HF trials
Trials by the same sponsor.
- NCT06901128 — The Covideo Study - a Trial of Cognitive Therapy for Social Anxiety Disorder in Youth, Comparing Screen to Office Delive · NA · recruiting
- NCT06790186 — Improving Real-world Function for Persons with Schizophrenia: a Single-case Experimental Design · NA · not yet recruiting
- NCT06403423 — Screening for Aortic Aneurysms in Inland Norway · enrolling by invitation
- NCT05874791 — Executive Control Training for Adolescents With ADHD: A Randomized Controlled Effectiveness Trial · NA · active not recruiting
- NCT07375615 — Continous Glucose Monitoring in Neonates at Risk of Hypoglycaemia- a Feasibility Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03881137 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sykehuset Innlandet HF
- Last refreshed: 9 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03881137.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing